79 related articles for article (PubMed ID: 10481525)
41. Effect on prognosis of bone marrow infiltration detected by magnetic resonance imaging in small cell lung cancer.
Seto T; Imamura F; Kuriyama K; Funakoshi T; Gotoh H; Nakayama T; Nakamura S; Horai T
Eur J Cancer; 1997 Dec; 33(14):2333-7. PubMed ID: 9616277
[TBL] [Abstract][Full Text] [Related]
42. [Value of bone marrow trephine biopsy in evaluating the extent of small cell lung cancer].
Zych J; Polowiec Z; Wiatr E; Broniek A; Grymiński J; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1993; 61(9-10):474-80. PubMed ID: 8111323
[TBL] [Abstract][Full Text] [Related]
43. A pilot evaluation of micrometastases for the prediction of outcome in lung cancer.
Thompson AB; Kessinger A; Sharp JG
Chest; 2004 May; 125(5 Suppl):156S-7S. PubMed ID: 15136484
[No Abstract] [Full Text] [Related]
44. [Clinical Analysis of Small Cell Lung Cancer with Bone Marrow Metastases].
Che Y; Luo Y; Wang D; Shen D; Yang L
Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):403-407. PubMed ID: 29764591
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies for the in vitro detection of small cell lung cancer metastases in human bone marrow.
Lebacq-Verheyden AM; Neirynck A; Ravoet AM; Humblet Y; Oie H; Linnoila I; Gazdar AF; Minna JD; Symann M
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):137-45. PubMed ID: 2833399
[TBL] [Abstract][Full Text] [Related]
46. Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer.
Skov BG; Hirsch FR; Bobrow L
Br J Cancer; 1992 Apr; 65(4):593-6. PubMed ID: 1373295
[TBL] [Abstract][Full Text] [Related]
47. Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging.
Imamura F; Kuriyama K; Seto T; Hasegawa Y; Nakayama T; Nakamura Si; Horai T
Lung Cancer; 2000 Mar; 27(3):189-97. PubMed ID: 10699692
[TBL] [Abstract][Full Text] [Related]
48. Examination of bone marrow biopsy specimens and staging of small cell lung cancer.
ten Velde GP; Kuypers-Engelen BT; Volovics A; Bosman FT
Eur J Cancer; 1990; 26(11-12):1142-5. PubMed ID: 1963546
[TBL] [Abstract][Full Text] [Related]
49. Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen.
Berendsen HH; de Leij L; Postmus PE; Ter Haar JG; Poppema S; The TH
J Clin Pathol; 1988 Mar; 41(3):273-6. PubMed ID: 2834417
[TBL] [Abstract][Full Text] [Related]
50. Detection of bone marrow micrometastasis.
Chen YH; Gao W; Zhou T; Zhao W; Zhao H; Liu D; Felber E
Hybridoma; 1999 Oct; 18(5):465-6. PubMed ID: 10600034
[TBL] [Abstract][Full Text] [Related]
51. Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies.
Trillet V; Revel D; Combaret V; Favrot M; Loire R; Tabib A; Pages J; Jacquemet P; Bonmartin A; Mornex JF
Br J Cancer; 1989 Jul; 60(1):83-8. PubMed ID: 2553088
[TBL] [Abstract][Full Text] [Related]
52. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables.
Tritz DB; Doll DC; Ringenberg QS; Anderson S; Madsen R; Perry MC; Yarbro JW
Cancer; 1989 Feb; 63(4):763-6. PubMed ID: 2536586
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic application of a monoclonal antibody against small cell lung cancer.
Postmus PE; Hirschler-Schulte TJ; De Leij L; Poppema S; Elema JE; Edens ET; Mesander G; Sluiter HJ; The TH
Cancer; 1986 Jan; 57(1):60-3. PubMed ID: 3000572
[TBL] [Abstract][Full Text] [Related]
54. Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC).
Hay FG; Ford A; Leonard RC
Int J Cancer Suppl; 1988; 2():8-10. PubMed ID: 2832333
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.
Vangsted AJ; Zeuthen J
Acta Oncol; 1993; 32(7-8):845-51. PubMed ID: 8305235
[TBL] [Abstract][Full Text] [Related]
56. Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations.
Pasini F; Pelosi G; Mostacci R; Santo A; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Ann Oncol; 1995 Jan; 6(1):86-8. PubMed ID: 7536032
[TBL] [Abstract][Full Text] [Related]
57. Assessment of bone marrow involvement by magnetic resonance imaging in small cell lung cancer. No significant change of staging.
Milleron BJ; Le Breton C; Carette MF; Cadranel JL; Akoun GM
Chest; 1994 Oct; 106(4):1030-5. PubMed ID: 7924470
[TBL] [Abstract][Full Text] [Related]
58. Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer.
Pasini F; Pelosi G; Verlato G; Guidi G; Pavanel F; Tummarello D; Masotti A; Cetto GL
Ann Oncol; 1998 Feb; 9(2):181-5. PubMed ID: 9553663
[TBL] [Abstract][Full Text] [Related]
59. Does bone marrow involvement affect prognosis in small-cell lung cancer?
Pasini F; Cetto GL; Pelosi G
Ann Oncol; 1998 Mar; 9(3):247-50. PubMed ID: 9602256
[No Abstract] [Full Text] [Related]
60. Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas.
Krishnan C; George TI; Arber DA
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):1-7. PubMed ID: 17536301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
